| 000 | 01136 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516052330.0 | ||
| 264 | 0 | _c20120131 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1946-6242 | ||
| 024 | 7 |
_a10.1126/scitranslmed.3001512 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLussier, Yves A | |
| 245 | 0 | 0 |
_aThe emergence of genome-based drug repositioning. _h[electronic resource] |
| 260 |
_bScience translational medicine _cAug 2011 |
||
| 300 |
_a96ps35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Comment | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xtherapeutic use |
| 650 | 0 | 4 |
_aComputational Biology _xmethods |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 | _aDrug Repositioning |
| 650 | 0 | 4 |
_aFructose _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 | _aTopiramate |
| 700 | 1 | _aChen, James L | |
| 773 | 0 |
_tScience translational medicine _gvol. 3 _gno. 96 _gp. 96ps35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/scitranslmed.3001512 _zAvailable from publisher's website |
| 999 |
_c21093237 _d21093237 |
||